Chirally correct retinal cyclodextrin hemiacetals for treating skin disorder
US8569269B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2013 |
| Grant date | Oct 29, 2013 |
| Priority date | — |
| Expiry date | Jun 17, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61Q19/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses a method of treating, reducing the occurrence of, or improving the symptoms associated with a skin condition by topical application of a compound of formula (I) or a salt thereof, wherein said skin condition is selected from the group consisting of melanogenesis, oxidative damage, inflammation, skin irritation from inflammation, loss of cell adhesion, loss of desquamation, extra-cellular including connective tissue matrix breakdown and skin tone loss thereof, loss of keratinization, cellular senescence, skin aging from cellular senescence, loss of skin whiteness, loss of skin barrier function, loss of skin firmness, rosacea, skin wrinkles and fine lines from cellular senescence, cellular oxidation, loss of skin collagen, topical wounds, and combinations thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.